There is a significant association between opioid exposure of the mother and increased risk of developmental delays in their babies, including but not limited to:

Speech delays

Impaired speech

Walking delays

Motor skill delays

Cognitive and learning delays

Hyperactivity and impulsivity

Attention Deficit Disorder

Behavioral Disorders and Aggressiveness

Poor social engagement

Propensity to addictive behaviors

The problems by in-vitro exposure of a fetus to prescription opioids are real and documented by science. A infant born opioid-dependent and sent home “opioid free” does not mean they have a guarantee of a healthy, normal life.

Claimant anonymity is allowed by law. The child can remain anonymous when a claim is filed. The guardian can also remain anonymous.